Navidea posts revenue declines, net loss increases in Q2
Radiopharmaceutical developer Navidea Biopharmaceuticals reported a declin...Read more on AuntMinnie.comRelated Reading:
Navidea highlights research on melanoma, oral cancer
Navidea touts clinical study using PET/CT for HIV infection
Navidea touts early results of RA study
Navidea secures Indian regulatory approval for Lymphoseek
NYSE accepts Navidea bid to comply with stock listing rules
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | India Health | Melanoma | Oral Cancer | Radiology | Skin Cancer | Study